麦肯锡公司支付了650M美元以解决帮助普渡制药公司销售阿片类药物的指控。 McKinsey & Company pays $650M to settle charges of aiding Purdue Pharma in opioid sales.

麦肯锡公司将支付6.5亿美元以解决联邦指控，这些指控帮助普渡制药公司提高了阿片类药物奥施康定的销售，导致了全国性的成瘾危机。 McKinsey & Company will pay $650 million to settle federal charges that it aided Purdue Pharma in boosting sales of the opioid OxyContin, contributing to the national addiction crisis. 作为协议的一部分，麦肯锡必须在五年内停止销售、营销或推广受控物质，以避免被起诉。 As part of the deal, McKinsey must stop working on the sale, marketing, or promotion of controlled substances for five years to avoid prosecution. 麦肯锡的一位前合伙人也同意承认销毁证据妨碍司法公正的罪名。 A former McKinsey partner also agreed to plead guilty to obstruction of justice for destroying evidence. 该和解标志着咨询公司首次因其在阿片类药物危机中的作用而被追究刑事责任。 The settlement marks the first time a consulting firm has been held criminally responsible for its role in the opioid crisis.